Literature DB >> 32040852

Fibroblasts in the Tumor Microenvironment.

Marta Truffi1,2, Luca Sorrentino2, Fabio Corsi3,4.   

Abstract

The implications of a tumor microenvironment in cancer initiation and progression have drawn interest in recent years. Within the tumor stroma, fibroblasts represent a predominant cell type and are responsible for the majority of extracellular components within the tumor microenvironment, such as matrix and soluble factors. A switch from quiescent fibroblasts to cancer-associated fibroblasts triggers a large variety of pro-tumorigenic signals that support tumor progression and shape the surrounding pathological stroma, with the remodeling of tissue architecture and repression of the local immune response. The heterogeneous nature of cancer-associated fibroblasts and their multiple functions are subject of active research as they could represent promising targets for cutting-edge therapeutic approaches to cancer and the tumor microenvironment.

Entities:  

Keywords:  Cancer treatment; Cancer-associated fibroblasts; Cancer-stroma crosstalk; Chemoresistance; Epithelial-to-mesenchymal transition; Extracellular matrix remodeling; Immunosuppression; Pro-tumorigenic cytokines; Targeted therapy; Tumor microenvironment; Tumor neoangiogenesis

Mesh:

Year:  2020        PMID: 32040852     DOI: 10.1007/978-3-030-37184-5_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

2.  Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.

Authors:  Izabela Szulc-Kielbik; Michal Kielbik
Journal:  Exp Suppl       Date:  2022

Review 3.  The Tumor Microenvironment: An Introduction to the Development of Microfluidic Devices.

Authors:  B Kundu; D Caballero; C M Abreu; R L Reis; S C Kundu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Clustering analysis and prognostic signature of lung adenocarcinoma based on the tumor microenvironment.

Authors:  Qingqing Shan; Yifan Zhang; Zongan Liang
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

5.  Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax.

Authors:  Leopoldo Sitia; Arianna Bonizzi; Serena Mazzucchelli; Sara Negri; Cristina Sottani; Elena Grignani; Maria Antonietta Rizzuto; Davide Prosperi; Luca Sorrentino; Carlo Morasso; Raffaele Allevi; Marta Sevieri; Filippo Silva; Marta Truffi; Fabio Corsi
Journal:  Cells       Date:  2021-02-05       Impact factor: 6.600

6.  Biological Function and Clinical Value of VPS13A in Pan-Cancer Based on Bioinformatics Analysis.

Authors:  Xue Qin Zhang; Li Li
Journal:  Int J Gen Med       Date:  2021-10-16

Review 7.  Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.

Authors:  Xiaoqi Mao; Jin Xu; Wei Wang; Chen Liang; Jie Hua; Jiang Liu; Bo Zhang; Qingcai Meng; Xianjun Yu; Si Shi
Journal:  Mol Cancer       Date:  2021-10-11       Impact factor: 27.401

Review 8.  Tumor Hybrid Cells: Nature and Biological Significance.

Authors:  Maria S Tretyakova; Ayalur R Subbalakshmi; Maxim E Menyailo; Mohit Kumar Jolly; Evgeny V Denisov
Journal:  Front Cell Dev Biol       Date:  2022-02-15

9.  Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk.

Authors:  Verena Damiani; Maria Concetta Cufaro; Maurine Fucito; Beatrice Dufrusine; Claudia Rossi; Piero Del Boccio; Luca Federici; Maria Caterina Turco; Michele Sallese; Damiana Pieragostino; Vincenzo De Laurenzi
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

Review 10.  Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.

Authors:  Marta Iozzo; Giovanna Sgrignani; Giuseppina Comito; Paola Chiarugi; Elisa Giannoni
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.